BONE-ALKALINE PHOSPHATASE AS INDICATOR OF BONE-FORMATION

被引:143
作者
VANSTRAALEN, JP [1 ]
SANDERS, E [1 ]
PRUMMEL, MF [1 ]
SANDERS, GTB [1 ]
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT ENDOCRINOL,1105 AZ AMSTERDAM,NETHERLANDS
关键词
BONE ALKALINE PHOSPHATASE; CORTICOSTEROID; CYCLOSPORINE; BECLOMETHASONE;
D O I
10.1016/0009-8981(91)90021-4
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Bone-alkaline phosphatase was determined in patients at risk of osteoporosis due to treatment with oral corticosteroids, and in patients at risk of increased bone synthesis because of treatment with cyclosporin. Both a significant decrease of bone-alkaline phosphatase during corticosteroid treatment, and a significant increase of bone-alkaline phosphatase during cyclosporin treatment could be demonstrated. It is concluded that bone-alkaline phosphatase is a useful parameter for monitoring changes in bone formation.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 13 条
  • [1] BEHR W, 1986, CLIN CHEM, V32, P1960
  • [2] CHYUN YS, 1984, ENDOCRINOLOGY, V114, P4770
  • [3] SERUM AND URINARY MARKERS OF BONE REMODELING - ASSESSMENT OF BONE TURNOVER
    EPSTEIN, S
    [J]. ENDOCRINE REVIEWS, 1988, 9 (04) : 437 - 449
  • [4] OSTEOCALCIN IN HUMAN-SERUM - A CIRCADIAN-RHYTHM
    GUNDBERG, CM
    MARKOWITZ, ME
    MIZRUCHI, M
    ROSEN, JF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) : 736 - 739
  • [5] GLUCOCORTICOID-INDUCED OSTEOPOROSIS - PATHOGENESIS AND MANAGEMENT
    LUKERT, BP
    RAISZ, LG
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (05) : 352 - 364
  • [6] SCREENING FOR OSTEOPOROSIS
    MELTON, LJ
    EDDY, DM
    JOHNSTON, CC
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (07) : 516 - 528
  • [7] MEUNIER PJ, 1984, ADV EXP MED BIOL, V171, P191
  • [8] BECLOMETHASONE INHALATION DECREASES SERUM OSTEOCALCIN CONCENTRATIONS
    POUW, EM
    PRUMMEL, MF
    OOSTING, H
    ROOS, CM
    ENDERT, E
    [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6777) : 627 - 628
  • [9] PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS
    REID, IR
    [J]. CLINICAL ENDOCRINOLOGY, 1989, 30 (01) : 83 - 103
  • [10] ROSALKI SB, 1984, CLIN CHEM, V30, P1182